SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 336.99 |
| Enterprise Value ($M) | 306.49 |
| Book Value ($M) | 300.05 |
| Book Value / Share | 11.68 |
| Price / Book | 1.12 |
| NCAV ($M) | 259.89 |
| NCAV / Share | 10.12 |
| Price / NCAV | 1.30 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.24 |
| Return on Assets (ROA) | -0.20 |
| Return on Equity (ROE) | -0.21 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 30.18 |
| Current Ratio | 30.18 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 268.84 |
| Assets | 309.00 |
| Liabilities | 8.95 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -89.73 |
| Net Income | -73.21 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -77.26 |
| Cash from Investing | -194.31 |
| Cash from Financing | 161.35 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Blue Owl Capital Holdings LP | 4.20 | -29.47 | |
| 13G/A | Ra Capital Management, L.p. | 9.90 | 24.15 | |
| 13G | Avoro Capital Advisors LLC | 8.70 | ||
| 13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
| 13G/A | Viking Global Investors Lp | 0.00 | ||
| 13G | BlackRock, Inc. | 6.80 | 0.00 | |
| 13G/A | Pfizer Inc | 4.96 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 71,488 | 263,497 | 27.13 | |
| 79,107 | 544,539 | 14.53 | |
| 83,788 | 346,806 | 24.16 | |
| 100,795 | 442,109 | 22.80 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TERN – Terns Pharmaceuticals, Inc. | TLRY – Tilray Brands, Inc. |
| TNYA – Tenaya Therapeutics, Inc. | TSHA – Taysha Gene Therapies, Inc. |
| TSVT – 2seventy bio, Inc. | |
Financial data and stock pages provided by
Fintel.io